Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements

v3.20.2
Fair Value Measurements
12 Months Ended
Sep. 30, 2020
Fair Value Measurements [Abstract]  
Fair Value Measurements

Note 3 – Fair Value Measurements



FASB ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions.



The three levels of the fair value hierarchy are as follows:



Level 1 – Quoted prices for identical instruments in active markets.



Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.



Level 3 – Instruments with primarily unobservable value drivers.



There were no transfers between Level 1, Level 2 and Level 3 during fiscal 2020 and 2019.



Amounts capitalized as IPR&D are subject to impairment testing until the completion or abandonment of the associated research and development efforts. During the fourth quarter of fiscal 2020, we recognized an impairment charge of $14.1 million associated with IPR&D intangible assets acquired in connection with the APP Acquisition. For the year ended September 30, 2020 we used probability-adjusted discounted cash flow calculations using Level 3 fair value measurements and inputs including estimated revenues, costs, probability of technical and regulatory success and discount rates to measure the impairment. See Note 8 for additional information.



As of September 30, 2020 and 2019, the Company’s financial liabilities measured at fair value on a recurring basis, which consisted of embedded derivatives, were classified within Level 3 of the fair value hierarchy.



The Company determines the fair value of hybrid instruments based on available market data using appropriate valuation models, considering all of the rights and obligations of each instrument. The Company estimates the fair value of hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair value. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating the fair value of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Increases in fair value during a given financial quarter result in the recognition of non-cash derivative expense. Conversely, decreases in fair value during a given financial quarter would result in the recognition of non-cash derivative income. 



The following table provides a reconciliation of the beginning and ending liability balance associated with embedded derivatives measured at fair value using significant unobservable inputs (Level 3) for the years ended September 30, 2020 and 2019:





 

 

 

 

 



2020

 

2019



 

 

 

 

 

Beginning balance

$

3,625,000 

 

$

2,426,000 

Change in fair value of derivative liabilities

 

557,000 

 

 

1,199,000 

Ending balance

$

4,182,000 

 

$

3,625,000 



The expense or income associated with the change in fair value of the embedded derivatives is presented as a separate line item in the accompanying consolidated statements of operations.



The liabilities associated with embedded derivatives represent the fair value of the change of control provisions in the Credit Agreement and Residual Royalty Agreement. See Note 9 for additional information. There is no current observable market for these types of derivatives. The Company determined the fair value of the embedded derivatives using a Monte Carlo simulation model to value the financial liabilities at inception and on subsequent valuation dates. This valuation model incorporates transaction details such as the contractual terms, expected cash outflows, expected repayment dates, probability of a change of control, expected volatility, and risk-free interest rates. The assumptions used in calculating the fair value of financial instruments represent the Company’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, the use of different estimates or assumptions would result in a higher or lower fair value and different amounts being recorded in the Company’s financial statements. Material changes in any of these inputs could result in a significantly higher or lower fair value measurement at future reporting dates, which could have a material effect on our results of operations. The increase in fair value of derivative liabilities in fiscal 2020 was driven by shifts in the estimated change of control dates, which brought the estimated change of control date closer to the balance sheet date, and an increase in the expected cash outflows under the Residual Royalty Agreement. The increase in fiscal 2019 was driven by an increase in the expected cash outflows under the Residual Royalty Agreement.



The following table presents quantitative information about the inputs and valuation methodologies used to determine the fair value of the embedded derivatives classified in Level 3 of the fair value hierarchy as of September 30, 2020 and 2019:



 

 

 

 

 

 



 

 

 

Weighted Average (range, if applicable)

Valuation Methodology

 

Significant Unobservable Input

 

2020

 

2019



 

 

 

 

 

 

Monte Carlo Simulation

 

Estimated change of control dates

 

December 2021 to June 2022

 

September 2020 to December 2021



 

Discount rate

 

14.1% to 16.0%

 

14.4% to 16.8%



 

Probability of change of control

 

20% to 90%

 

10% to 90%